{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:40:47Z","timestamp":1786120847850,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","award":["448"],"award-info":[{"award-number":["448"]}],"id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["101081481"],"award-info":[{"award-number":["101081481"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["ONCODE"],"award-info":[{"award-number":["ONCODE"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021820","name":"Stichting Prinses M\u00e1xima Centrum","doi-asserted-by":"publisher","award":["Stichting Prinses M\u00e1xima Centrum"],"award-info":[{"award-number":["Stichting Prinses M\u00e1xima Centrum"]}],"id":[{"id":"10.13039\/501100021820","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00405-026-10236-6","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:00:41Z","timestamp":1777996841000},"page":"4815-4826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prestin as a potential biomarker for cochlear injury: Current evidence and future directions"],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3362-6953","authenticated-orcid":false,"given":"Nienke","family":"Streefkerk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6899-1519","authenticated-orcid":false,"given":"Regina","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1727-1389","authenticated-orcid":false,"given":"Alice I. E.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9422-4897","authenticated-orcid":false,"given":"Kim E.","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7417-5546","authenticated-orcid":false,"given":"Alexander E.","family":"Hoetink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9690-1385","authenticated-orcid":false,"given":"Wilbert P.","family":"Vermeij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1939-4639","authenticated-orcid":false,"given":"Alwin D. R.","family":"Huitema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8849-8573","authenticated-orcid":false,"given":"Martine","family":"van Grotel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-879X","authenticated-orcid":false,"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"10236_CR1","doi-asserted-by":"publisher","unstructured":"BrockP, Rajput K, Edwards L, Meijer A, Simpkin P, Hoetink A (2021) Cisplatin Ototoxicity in Children. https:\/\/doi.org\/10.5772\/intechopen.96744","DOI":"10.5772\/intechopen.96744"},{"issue":"2","key":"10236_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/08880018.2017.1323985","volume":"34","author":"E Clemens","year":"2017","unstructured":"Clemens E, de Vries AC, Zehnhoff-Dinnesen A, Tissing A, Loonen WJ, Pluijm JJ (2017) Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors. Pediatr Hematol Oncol 34(2):120\u2013129. https:\/\/doi.org\/10.1080\/08880018.2017.1323985","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"10236_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00000421-199906000-00020","volume":"22","author":"JL Nagy","year":"1999","unstructured":"Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P (1999) Cisplatin ototoxicity: the importance of baseline audiometry. Am J Clin Oncol 22(3):305\u2013308. https:\/\/doi.org\/10.1097\/00000421-199906000-00020","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10236_CR4","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/s1470-2045(18)30858-1","volume":"20","author":"E Clemens","year":"2019","unstructured":"Clemens E, van den Heuvel-Eibrink MM, Mulder RL, Kremer LCM, Hudson MM, Skinner R et al (2019) Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Lancet Oncol 20(1):e29\u2013e41. https:\/\/doi.org\/10.1016\/s1470-2045(18)30858-1","journal-title":"Lancet Oncol"},{"issue":"1","key":"10236_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00178-z","volume":"5","author":"AJM Meijer","year":"2021","unstructured":"Meijer AJM, Diepstraten FA, Langer T, Broer L, Domingo IK, Clemens E et al (2021) TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. npj Precis Oncol 5(1):64. https:\/\/doi.org\/10.1038\/s41698-021-00178-z","journal-title":"npj Precis Oncol"},{"issue":"3","key":"10236_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/ftd.0000000000001085","volume":"45","author":"A Siemens","year":"2023","unstructured":"Siemens A, Brooks B, Rassekh SR, Meijer AJM, van den Heuvel-Eibrink MM, Xu W et al (2023) Role of cisplatin dose intensity and TPMT variation in the development of hearing loss in children. Ther Drug Monit 45(3):345\u201353. https:\/\/doi.org\/10.1097\/ftd.0000000000001085","journal-title":"Ther Drug Monit"},{"issue":"16","key":"10236_CR7","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","volume":"40","author":"Y Li","year":"2004","unstructured":"Li Y, Womer RB, Silber JH (2004) Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur J Cancer 40(16):2445\u20132451. https:\/\/doi.org\/10.1016\/j.ejca.2003.08.009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10236_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/cncr.33848","volume":"128","author":"AJM Meijer","year":"2022","unstructured":"Meijer AJM, Li KH, Brooks B, Clemens E, Ross CJ, Rassekh SR et al (2022) The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. Cancer 128(1):169\u201379. https:\/\/doi.org\/10.1002\/cncr.33848","journal-title":"Cancer"},{"issue":"1","key":"10236_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1152\/physrev.00044.2006","volume":"88","author":"J Ashmore","year":"2008","unstructured":"Ashmore J (2008) Cochlear outer hair cell motility. Physiol Rev 88(1):173\u2013210. https:\/\/doi.org\/10.1152\/physrev.00044.2006","journal-title":"Physiol Rev"},{"issue":"6","key":"10236_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1017\/s0022215113000947","volume":"127","author":"MS Gon\u00e7alves","year":"2013","unstructured":"Gon\u00e7alves MS, Silveira AF, Teixeira AR, Hyppolito MA (2013) Mechanisms of cisplatin ototoxicity: theoretical review. J Laryngol Otol 127(6):536\u2013541. https:\/\/doi.org\/10.1017\/s0022215113000947","journal-title":"J Laryngol Otol"},{"key":"10236_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1197051","volume":"17","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang T, Song Q, Gao D, Li Y, Jie H et al (2023) Cisplatin ototoxicity mechanism and antagonistic intervention strategy: A scope review. Front Cell Neurosci 17:1197051. https:\/\/doi.org\/10.3389\/fncel.2023.1197051","journal-title":"Front Cell Neurosci"},{"key":"10236_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1245434","volume":"17","author":"A Podury","year":"2023","unstructured":"Podury A, Jiam NT, Kim M, Donnenfield JI, Dhand A (2023) Hearing and sociality: The implications of hearing loss on social life. Front Neurosci 17:1245434. https:\/\/doi.org\/10.3389\/fnins.2023.1245434","journal-title":"Front Neurosci"},{"issue":"34","key":"10236_CR13","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1200\/jco.2004.00.5355","volume":"23","author":"KR Knight","year":"2005","unstructured":"Knight KR, Kraemer DF, Neuwelt EA (2005) Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 23(34):8588\u20138596. https:\/\/doi.org\/10.1200\/jco.2004.00.5355","journal-title":"J Clin Oncol"},{"issue":"10","key":"10236_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/14992027.2016.1185168","volume":"55","author":"S Tegg-Quinn","year":"2016","unstructured":"Tegg-Quinn S, Bennett RJ, Eikelboom RH, Baguley DM (2016) The impact of tinnitus upon cognition in adults: A systematic review. Int J Audiol 55(10):533\u2013540. https:\/\/doi.org\/10.1080\/14992027.2016.1185168","journal-title":"Int J Audiol"},{"key":"10236_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-024-01617-z","author":"A Maas","year":"2024","unstructured":"Maas A, Maurice-Stam H, Feijen L, Teepen JC, van der Aa-van Delden AM, Streefkerk N et al (2024) The impact of clinically relevant health conditions on psychosocial outcomes in survivors of childhood cancer: Results of the DCCSS-LATER study. J Cancer Surviv. https:\/\/doi.org\/10.1007\/s11764-024-01617-z","journal-title":"J Cancer Surviv"},{"issue":"25","key":"10236_CR16","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","volume":"378","author":"PR Brock","year":"2018","unstructured":"Brock PR, Maibach R, Childs M, Rajput K, Roebuck D, Sullivan MJ et al (2018) Sodium thiosulfate for protection from cisplatin-induced hearing loss. N Engl J Med 378(25):2376\u201385. https:\/\/doi.org\/10.1056\/NEJMoa1801109","journal-title":"N Engl J Med"},{"issue":"1","key":"10236_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s1470-2045(16)30625-8","volume":"18","author":"DR Freyer","year":"2017","unstructured":"Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B et al (2017) Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): A multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Oncol 18(1):63\u201374. https:\/\/doi.org\/10.1016\/s1470-2045(16)30625-8","journal-title":"Lancet Oncol"},{"key":"10236_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1336714","volume":"14","author":"AJM Meijer","year":"2024","unstructured":"Meijer AJM, Diepstraten FA, van den Heuvel-Eibrink MM, Bleyer A (2024) Prevention of cisplatin-induced hearing loss in children: achievements and challenges for evidence-based implementation of sodium Thiosulfate. Front Oncol 14:1336714. https:\/\/doi.org\/10.3389\/fonc.2024.1336714","journal-title":"Front Oncol"},{"issue":"5","key":"10236_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30248","volume":"70","author":"P Brock","year":"2023","unstructured":"Brock P, Meijer A, Kogner P, Ansari M, Capra M, Geller J et al (2023) Sodium thiosulfate as cisplatin otoprotectant in children: the challenge of when to use it. Pediatr Blood Cancer 70(5):e30248. https:\/\/doi.org\/10.1002\/pbc.30248","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10236_CR20","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1097\/mao.0000000000001164","volume":"37","author":"K Parham","year":"2016","unstructured":"Parham K, Dyhrfjeld-Johnsen J (2016) Outer hair cell molecular protein, prestin, as a serum biomarker for hearing loss: proof of concept. Otol Neurotol 37(9):1217\u20131222. https:\/\/doi.org\/10.1097\/mao.0000000000001164","journal-title":"Otol Neurotol"},{"issue":"5","key":"10236_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109097","volume":"35","author":"XD Zhang","year":"2021","unstructured":"Zhang XD, Thai PN, Ren L, Perez Flores MC, Ledford HA, Park S et al (2021) Prestin amplifies cardiac motor functions. Cell Rep 35(5):109097. https:\/\/doi.org\/10.1016\/j.celrep.2021.109097","journal-title":"Cell Rep"},{"issue":"11","key":"10236_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217891120","volume":"120","author":"S Takahashi","year":"2023","unstructured":"Takahashi S, Zhou Y, Kojima T, Cheatham MA, Homma K (2023) Prestin\u2019s fast motor kinetics is essential for mammalian cochlear amplification. Proc Natl Acad Sci U S A 120(11):e2217891120. https:\/\/doi.org\/10.1073\/pnas.2217891120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10236_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2021.108428","volume":"423","author":"J Zheng","year":"2022","unstructured":"Zheng J, Takahashi S, Zhou Y, Cheatham MA (2022) Prestin and electromotility may serve multiple roles in cochlear outer hair cells. Hear Res 423:108428. https:\/\/doi.org\/10.1016\/j.heares.2021.108428","journal-title":"Hear Res"},{"issue":"18","key":"10236_CR24","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1016\/j.cell.2021.07.034","volume":"184","author":"J Ge","year":"2021","unstructured":"Ge J, Elferich J, Dehghani-Ghahnaviyeh S, Zhao Z, Meadows M, von Gersdorff H et al (2021) Molecular mechanism of prestin electromotive signal amplification. Cell 184(18):4669\u201379.e13. https:\/\/doi.org\/10.1016\/j.cell.2021.07.034","journal-title":"Cell"},{"issue":"1","key":"10236_CR25","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41598-022-05131-z","volume":"12","author":"A Parker","year":"2022","unstructured":"Parker A, Parham K, Skoe E (2022) Noise exposure levels predict blood levels of the inner ear protein prestin. Sci Rep 12(1):1154. https:\/\/doi.org\/10.1038\/s41598-022-05131-z","journal-title":"Sci Rep"},{"issue":"5","key":"10236_CR26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/aud.0000000000001026","volume":"42","author":"A Parker","year":"2021","unstructured":"Parker A, Parham K, Skoe E (2021) Reliability of serological Prestin levels in humans and its relation to otoacoustic emissions, a functional measure of outer hair cells. Ear Hear 42(5):1151\u20131162. https:\/\/doi.org\/10.1097\/aud.0000000000001026","journal-title":"Ear Hear"},{"issue":"1\u20132","key":"10236_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.heares.2006.04.001","volume":"218","author":"KA Abrashkin","year":"2006","unstructured":"Abrashkin KA, Izumikawa M, Miyazawa T, Wang CH, Crumling MA, Swiderski DL et al (2006) The fate of outer hair cells after acoustic or ototoxic insults. Hear Res 218(1\u20132):20\u20139. https:\/\/doi.org\/10.1016\/j.heares.2006.04.001","journal-title":"Hear Res"},{"issue":"1","key":"10236_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00441-015-2113-z","volume":"361","author":"DN Furness","year":"2015","unstructured":"Furness DN (2015) Molecular basis of hair cell loss. Cell Tissue Res 361(1):387\u2013. https:\/\/doi.org\/10.1007\/s00441-015-2113-z. 99","journal-title":"Cell Tissue Res"},{"key":"10236_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"J Hayden","year":"2013","unstructured":"Hayden J, van der Windt D, Cartwright J, C\u00f4t\u00e9 P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280\u2013286. https:\/\/doi.org\/10.7326\/0003-4819-158-4-201302190-00009","journal-title":"Ann Intern Med"},{"issue":"5","key":"10236_CR30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.amjoto.2018.07.007","volume":"39","author":"M Dogan","year":"2018","unstructured":"Dogan M, Sahin M, Cetin N, Yilmaz M, Demirci B (2018) Utilizing Prestin as a predictive marker for the early detection of outer hair cell damage. Am J Otolaryngol 39(5):594\u2013598. https:\/\/doi.org\/10.1016\/j.amjoto.2018.07.007","journal-title":"Am J Otolaryngol"},{"key":"10236_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.heares.2018.11.013","volume":"371","author":"K Parham","year":"2019","unstructured":"Parham K, Sohal M, Petremann M, Romanet C, Broussy A, Tran Van Ba C, Dyhrfjeld-Johnsen J (2019) Noise-induced trauma produces a temporal pattern of change in blood levels of the outer hair cell biomarker Prestin. Hear Res 371:98\u2013104. https:\/\/doi.org\/10.1016\/j.heares.2018.11.013","journal-title":"Hear Res"},{"issue":"1","key":"10236_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23034-x","volume":"12","author":"C Generotti","year":"2022","unstructured":"Generotti C, Cox BC, Singh J, Hamilton D, McKenzie E, O\u2019Malley BW Jr., Li D (2022) Subclinical diagnosis of cisplatin-induced ototoxicity with biomarkers. Sci Rep 12(1):18032. https:\/\/doi.org\/10.1038\/s41598-022-23034-x","journal-title":"Sci Rep"},{"issue":"3","key":"10236_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/0194599817742093","volume":"158","author":"J Naples","year":"2018","unstructured":"Naples J, Cox R, Bonaiuto G, Parham K (2018) Prestin as an otologic biomarker of cisplatin ototoxicity in a guinea pig model. Otolaryngol Head Neck Surg 158(3):541\u2013546. https:\/\/doi.org\/10.1177\/0194599817742093","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"10","key":"10236_CR34","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1097\/mao.0000000000001616","volume":"38","author":"B Liba","year":"2017","unstructured":"Liba B, Naples J, Bezyk E, Campbell C, Mei M, Parham K (2017) Changes in serum Prestin concentration after exposure to Cisplatin. Otol Neurotol 38(10):e501\u2013e5. https:\/\/doi.org\/10.1097\/mao.0000000000001616","journal-title":"Otol Neurotol"},{"issue":"3","key":"10236_CR35","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00405-022-07586-2","volume":"280","author":"RH Asli","year":"2023","unstructured":"Asli RH, Akbarpour M, Lahiji MR, Leyli EK, Pastadast M, Ramezani H, Nemati S (2023) Evaluation of the relationship between Prestin serum biomarker and sensorineural hearing loss: a case-control study. Eur Arch Otorhinolaryngol 280(3):1147\u20131153. https:\/\/doi.org\/10.1007\/s00405-022-07586-2","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"10236_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.anl.2021.09.010","volume":"49","author":"S Emre","year":"2022","unstructured":"Emre S, Karlidag T, Ayd\u0131n S, Kaygusuz I, Keles E, Akyigit A, Yalcin S (2022) Can Prestin level be a biomarker for determining sensorineural hearing loss? Auris Nasus Larynx 49(3):368\u201373. https:\/\/doi.org\/10.1016\/j.anl.2021.09.010","journal-title":"Auris Nasus Larynx"},{"issue":"6","key":"10236_CR37","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1007\/s00405-021-06967-3","volume":"279","author":"MM Jalali","year":"2022","unstructured":"Jalali MM, Saedi HS, Saadat F (2022) Effect of Cisplatin chemotherapy on the inner ear function and serum Prestin concentration. Eur Arch Otorhinolaryngol 279(6):2783\u20132789. https:\/\/doi.org\/10.1007\/s00405-021-06967-3","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"10236_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/aud.0000000000001123","volume":"43","author":"JG Naples","year":"2022","unstructured":"Naples JG, Soda D, Rahman K, Ruckenstein MJ, Parham K (2022) Evaluating the role of otologic biomarkers to differentiate Meniere\u2019s disease and vestibular migraine. Ear Hear 43(2):699\u2013702. https:\/\/doi.org\/10.1097\/aud.0000000000001123","journal-title":"Ear Hear"},{"key":"10236_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2022.108640","volume":"426","author":"A Parker","year":"2022","unstructured":"Parker A, Parham K, Skoe E (2022) Age-related declines to serum Prestin levels in humans. Hear Res 426:108640. https:\/\/doi.org\/10.1016\/j.heares.2022.108640","journal-title":"Hear Res"},{"issue":"8","key":"10236_CR40","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1177\/0145561319849949","volume":"99","author":"C Sun","year":"2020","unstructured":"Sun C, Xuan X, Zhou Z, Yuan Y, Xue F (2020) A preliminary report on the investigation of Prestin as a biomarker for idiopathic sudden sensorineural hearing loss. Ear Nose Throat J 99(8):528\u2013531. https:\/\/doi.org\/10.1177\/0145561319849949","journal-title":"Ear Nose Throat J"},{"issue":"6","key":"10236_CR41","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/ohn.895","volume":"171","author":"AJ Gadenstaetter","year":"2024","unstructured":"Gadenstaetter AJ, Krumpoeck PE, Auinger AB, Yildiz E, Tu A, Matula C et al (2024) Prestin in human perilymph, cerebrospinal fluid, and blood as a biomarker for hearing loss. Otolaryngol Head Neck Surg 171(6):1825\u201333. https:\/\/doi.org\/10.1002\/ohn.895","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10236_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2023.101380","volume":"90","author":"A Baskadem Yilmazer","year":"2024","unstructured":"Baskadem Yilmazer A, Tanr\u0131sever O, Alagoz MH, Yilmazer R, Goker AE, Tutar B, Uyar Y (2024) Evaluation of inner ear damage by mastoid drilling with measurement of serum Prestin (SLC26A5) levels. Braz J Otorhinolaryngol 90(2):101380. https:\/\/doi.org\/10.1016\/j.bjorl.2023.101380","journal-title":"Braz J Otorhinolaryngol"},{"key":"10236_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115651","volume":"426","author":"S Solis-Angeles","year":"2021","unstructured":"Solis-Angeles S, Ju\u00e1rez-P\u00e9rez CA, Jim\u00e9nez-Ram\u00edrez C, Cabello-L\u00f3pez A, Aguilar-Madrid G, Del Razo LM (2021) Prestin and Otolin-1 proteins in the hearing loss of adults chronically exposed to lead. Toxicol Appl Pharmacol 426:115651. https:\/\/doi.org\/10.1016\/j.taap.2021.115651","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"10236_CR44","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1017\/s0022215121003108","volume":"136","author":"F Saadat","year":"2022","unstructured":"Saadat F, Jalali MM, Akbari M (2022) Assessment of Prestin level changes as an inner-ear biomarker in patients with idiopathic sudden sensorineural hearing loss. J Laryngol Otol 136(11):1039\u20131043. https:\/\/doi.org\/10.1017\/s0022215121003108","journal-title":"J Laryngol Otol"},{"issue":"2","key":"10236_CR45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53763","volume":"16","author":"ARH Al Samarrai","year":"2024","unstructured":"Al Samarrai ARH, Mahdi BM, Parham K (2024) Relationship of serum Prestin levels to the severity of sensorineural hearing loss. Cureus 16(2):e53763. https:\/\/doi.org\/10.7759\/cureus.53763","journal-title":"Cureus"},{"issue":"4","key":"10236_CR46","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/aud.0000000000001499","volume":"45","author":"E Iliadou","year":"2024","unstructured":"Iliadou E, Plack CJ, Pastiadis K, Bibas A (2024) Serum Prestin level may increase following music exposure that induces temporary threshold shifts: A pilot study. Ear Hear 45(4):1059\u20131069. https:\/\/doi.org\/10.1097\/aud.0000000000001499","journal-title":"Ear Hear"},{"issue":"3","key":"10236_CR47","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55936","volume":"16","author":"P Minoretti","year":"2024","unstructured":"Minoretti P, Santiago S\u00e1ez A, Lia\u00f1o Riera M, G\u00f3mez Serrano M, Garc\u00eda Mart\u00edn \u00c1 (2024) Serum Prestin and Otolin-1 levels in pilots of helicopter-based emergency medical services: Potential markers for ear injury. Cureus 16(3):e55936. https:\/\/doi.org\/10.7759\/cureus.55936","journal-title":"Cureus"},{"issue":"12","key":"10236_CR48","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.75719","volume":"16","author":"JW Lee","year":"2024","unstructured":"Lee JW, Miser S, O\u2019Connor K, Bedinghaus C, Tomeo G, Badawy M, Millner D (2024) Changes in plasma levels of Prestin and Otolin-1 in dental students. Cureus 16(12):e75719. https:\/\/doi.org\/10.7759\/cureus.75719","journal-title":"Cureus"},{"issue":"5","key":"10236_CR49","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/aud.0000000000001045","volume":"42","author":"E Iliadou","year":"2021","unstructured":"Iliadou E, Kikidis D, Pastiadis K, Plack CJ, Bibas A (2021) Blood Prestin levels in normal hearing and in sensorineural hearing loss: A scoping review. Ear Hear 42(5):1127\u20131136. https:\/\/doi.org\/10.1097\/aud.0000000000001045","journal-title":"Ear Hear"},{"issue":"6","key":"10236_CR50","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/ohn.915","volume":"171","author":"C Malesky","year":"2024","unstructured":"Malesky C, Daniel D, Skoe E, Parham K (2024) Serum levels of stereocilin as a hearing biomarker. Otolaryngol Head Neck Surg 171(6):1934\u20131937. https:\/\/doi.org\/10.1002\/ohn.915","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"10236_CR51","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.bjorl.2021.01.004","volume":"88","author":"YS \u00c7etin","year":"2022","unstructured":"\u00c7etin YS, Bozan N, Avc\u0131 K, Aslan M, Erel \u00d6 (2022) The relationship between thiol-disulfide balance and idiopathic sudden sensorineural hearing loss. Braz J Otorhinolaryngol 88(6):948\u2013953. https:\/\/doi.org\/10.1016\/j.bjorl.2021.01.004","journal-title":"Braz J Otorhinolaryngol"},{"issue":"2","key":"10236_CR52","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/clinchem\/hvaa233","volume":"67","author":"A Co\u015fkun","year":"2021","unstructured":"Co\u015fkun A, Sandberg S, Unsal I, Cavusoglu C, Serteser M, Kilercik M, Aarsand AK (2021) Personalized reference intervals in laboratory medicine: A new model based on within-subject biological variation. Clin Chem 67(2):374\u2013384. https:\/\/doi.org\/10.1093\/clinchem\/hvaa233","journal-title":"Clin Chem"},{"issue":"4","key":"10236_CR53","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1021\/acs.jproteome.1c00935","volume":"21","author":"A Vignoli","year":"2022","unstructured":"Vignoli A, Tenori L, Morsiani C, Turano P, Capri M, Luchinat C (2022) Serum or plasma (and which plasma), that is the question. J Proteome Res 21(4):1061\u201372. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00935","journal-title":"J Proteome Res"},{"issue":"4","key":"10236_CR54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1515\/cclm.2006.073","volume":"44","author":"G Lippi","year":"2006","unstructured":"Lippi G, Guidi GC, Mattiuzzi C, Plebani M (2006) Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 44(4):358\u2013365. https:\/\/doi.org\/10.1515\/cclm.2006.073","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"10236_CR55","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24(8):971\u2013983. https:\/\/doi.org\/10.1038\/nbt1235","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10236_CR56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/pbc.22876","volume":"56","author":"EJ Einarsson","year":"2011","unstructured":"Einarsson EJ, \u00d3skarsson T, Haraldsson A, Mo\u00ebll C, Wiebe T, Magnusson M et al (2011) Hearing impairment after platinum-based chemotherapy in childhood. Pediatr Blood Cancer 56(4):631\u20137. https:\/\/doi.org\/10.1002\/pbc.22876","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10236_CR57","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1200\/JCO.2016.69.2319","volume":"35","author":"KR Knight","year":"2017","unstructured":"Knight KR, Chen L, Freyer D, Aplenc R, Bancroft M, Bliss B et al (2017) Group-wide, prospective study of ototoxicity assessment in children receiving Cisplatin chemotherapy (ACCL05C1): A report from the Children\u2019s Oncology Group. J Clin Oncol 35(4):440\u20135. https:\/\/doi.org\/10.1200\/JCO.2016.69.2319","journal-title":"J Clin Oncol"},{"issue":"11","key":"10236_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.70046","volume":"7","author":"FA Diepstraten","year":"2024","unstructured":"Diepstraten FA, Bertram OMM, Helleman HW, Boerboom RA, van Grotel M, Zs\u00edros J et al (2024) A retrospective evaluation of ototoxicity monitoring in a cohort of pediatric patients with solid tumors, treated in the Dutch National Cancer Center. Cancer Rep 7(11):e70046. https:\/\/doi.org\/10.1002\/cnr2.70046","journal-title":"Cancer Rep"},{"issue":"10","key":"10236_CR59","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jamaoncol.2021.2697","volume":"7","author":"AJM Meijer","year":"2021","unstructured":"Meijer AJM, van den Heuvel Eibrink MM, Brooks B, Am Zehnhoff-Dinnesen AG, Knight KR, Freyer DR et al (2021) Recommendations for age-appropriate testing, timing, and frequency of audiologic monitoring during childhood cancer treatment: an International Society of Paediatric Oncology Supportive Care Consensus Report. JAMA Oncol 7(10):1550\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2021.2697","journal-title":"JAMA Oncol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10236-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10236-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10236-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:52:21Z","timestamp":1786063941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10236-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10236"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10236-6","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}